Active ingredient:
Ondansetron 8 mg.
Therapeutic indications:
Indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, prevention and treatment of postoperative nausea and vomiting (PONV).
Dosage form
Solution for Intramuscular or Intravenous Injection or Intravenous Infusion.
